Login Register Cart 0
Generic placeholder image

Current Functional Foods

Editor-in-Chief

ISSN (Print): 2666-8629
ISSN (Online): 2666-8637

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Review Article

Phytopharmacological update on Cannabis sativa (Ganja): A Mini Review

In Press, (this is not the final "Version of Record"). Available online 20 March, 2024
Author(s): Tushar Varshney, Mohit Sanduja, Devender Pathak, Anuj Kumar Sharma, Vibha Kumari, Manjul Pratap Singh and Mayank Kulshreshtha*
Published on: 20 March, 2024

Article ID: e200324228176

DOI: 10.2174/0126668629285842240303141227

Price: $95

Abstract

Cannabis sativa L., a significant herbaceous species in Central Asia, has long been valued for its use in traditional medicine and as a source of textile fiber. This fast-growing plant has recently drawn increased attention because of its many applications. It is an abundant source of wood and cellulosic fibers and a true treasure of phytochemicals. This plant greatly interests the construction and pharmaceutical sectors because its metabolites have potent biological ef-fects on human health. Its inner and outer stem tissues may be used to make concrete-like mate-rials and bioplastics. This study aims to summarize the molecular and scientific knowledge of Cannabis sativa, including its pharmacognostic properties, pharmacological potential, phyto-chemical properties, and prospective future research fields.

[1]
Sofowora A, Ogunbodede E, Onayade A. The role and place of medicinal plants in the strategies for disease prevention. Afr J Tradit Complement Altern Med 2013; 10(5): 210-29.
[2]
Evans WC. Trease and Evans’ Pharmacognosy. (16th ed.), London: WB Saunders Company Ltd 2008.
[3]
Sofowora A. Medicinal plants and traditional medicine in Africa. (3rd ed.), Ibadan: Spectrum Books 2008.
[4]
Andre CM, Hausman JF, Guerriero G. Cannabis sativa: The plant of the thousand and one molecules. Front Plant Sci 2016; 7: 19.
[http://dx.doi.org/10.3389/fpls.2016.00019] [PMID: 26870049]
[5]
ElSohly MA, Radwan MM, Gul W, Chandra S, Galal A. Phytochemistry of Cannabis sativa L. Prog Chem Org Nat Prod 2017; 103: 1-36.
[http://dx.doi.org/10.1007/978-3-319-45541-9_1] [PMID: 28120229]
[6]
Baldino L, Scognamiglio M, Reverchon E. Supercritical fluid technologies applied to the extraction of compounds of industrial interest from Cannabis sativa L. and to their pharmaceutical formulations: A review. J Supercrit Fluids 2020; 165: 104960.
[http://dx.doi.org/10.1016/j.supflu.2020.104960]
[7]
Brunetti P, Pichini S, Pacifici R, Busardò FP, del Rio A. Herbal preparations of medical cannabis: A vademecum for prescribing doctors. Medicina 2020; 56(5): 237.
[http://dx.doi.org/10.3390/medicina56050237] [PMID: 32429074]
[8]
Lewis MM, Yang Y, Wasilewski E, Clarke HA, Kotra LP. Chemical profiling of medical Cannabis extracts. ACS Omega 2017; 2(9): 6091-103.
[http://dx.doi.org/10.1021/acsomega.7b00996] [PMID: 30023762]
[9]
Odieka AE, Obuzor GU, Oyedeji OO, Gondwe M, Hosu YS, Oyedeji AO. The medicinal natural products of Cannabis sativa Linn.: A review. Molecules 2022; 27(5): 1689.
[http://dx.doi.org/10.3390/molecules27051689] [PMID: 35268790]
[10]
WHO World Health Organization. 2016. Available from: https://www.who.int/publications/i/item/9789241510240
[11]
UNODC. 2016. Available from: https://www.unodc.org/e4j/en/crime-prevention-criminal-justice/module-12/index.html
[12]
Modaresi F, Talachian K. The characteristics of clinical trials on cannabis and cannabinoids: a review of trials for therapeutic or drug development purposes. Pharmaceut Med 2022; 36(6): 387-400.
[http://dx.doi.org/10.1007/s40290-022-00447-7] [PMID: 36357543]
[13]
Available from: https://sites.google.com/site/indiannamesofplants/via-species/c/cannabis-sativa (Assessed 23-02-2023).
[14]
Marijuana Available from: http://www.flowersofindia.net/catalog/slides/Marijuana.html (Assessed 23-02-2023).
[15]
Available from: https://www.google.com/search?q=cannabis+sativa+agriculture&rlz=1C1ONGR
[16]
Available from: https://www.google.com/search?q=Traditional+use+of+cannabis+sativa+&rlz=1C1ONGR_enIN1021IN1021
[17]
Available from: https://gobotany.nativeplanttrust.org/species/cannabis/sativa/ (Assessed 27-02-2023).
[18]
Russo EB. History of cannabis and its preparations in saga, science, and sobriquet. Chem Biodivers 2007; 4(8): 1614-48.
[http://dx.doi.org/10.1002/cbdv.200790144] [PMID: 17712811]
[19]
Rajavashisth TB, Shaheen M, Norris KC, et al. Decreased prevalence of diabetes in marijuana users: cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) III. BMJ Open 2012; 2(1): e000494.
[http://dx.doi.org/10.1136/bmjopen-2011-000494] [PMID: 22368296]
[20]
Cao R, Wang J, Zhang W, et al. Is Marijuana beneficial for prevention and treatment of diabetes? Am J Biomed Sci 2017; 9: 200-10.
[http://dx.doi.org/10.5099/aj170400200]
[21]
Levendal RA, Frost CL. In vivo effects of Cannabis sativa L. extract on blood coagulation, fat and glucose metabolism in normal and streptozocin-induced diabetic rats. Afr J Tradit Complement Altern Med 2006; 3(4): 1-12.
[http://dx.doi.org/10.4314/ajtcam.v3i4.31172]
[22]
Ramer R, Hinz B. New insights into antimetastatic and antiangiogenic effects of cannabinoids. Int Rev Cell Mol Biol 2015; 314: 43-116.
[http://dx.doi.org/10.1016/bs.ircmb.2014.10.005] [PMID: 25619715]
[23]
MacHado Rocha FC, Stéfano SC, De Cássia Haiek R, Rosa Oliveira LMQ, Da Silveira DX. Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: Systematic review and meta-analysis. Eur J Cancer Care 2008; 17(5): 431-43.
[http://dx.doi.org/10.1111/j.1365-2354.2008.00917.x] [PMID: 18625004]
[24]
Alexander A, Smith PF, Rosengren RJ. Cannabinoids in the treatment of cancer. Cancer Lett 2009; 285(1): 6-12.
[http://dx.doi.org/10.1016/j.canlet.2009.04.005] [PMID: 19442435]
[25]
Freimuth N, Ramer R, Hinz B. Antitumorigenic effects of cannabinoids beyond apoptosis. J Pharmacol Exp Ther 2010; 332(2): 336-44.
[http://dx.doi.org/10.1124/jpet.109.157735] [PMID: 19889794]
[26]
Sevcík J, Masek K. Potential role of cannabinoids in Parkinson’s disease. Drugs Aging 2000; 16(6): 391-5.
[http://dx.doi.org/10.2165/00002512-200016060-00001] [PMID: 10939305]
[27]
Hernandez F, Chandra S. The current state and potential direction of cannabis research. J Complement Integr Med 2016; 6: 44-8.
[28]
Sharma SR, Gupta P, Kumar R, Singh B. Marijuana from poison to pills A Review JIAFM 2006; 28: 162-9.
[29]
Tomida I, Pertwee RG, Azuara-Blanco A. Cannabinoids and glaucoma. Br J Ophthalmol 2004; 88(5): 708-13.
[http://dx.doi.org/10.1136/bjo.2003.032250] [PMID: 15090428]
[30]
Swift W, Gates P, Dillon P. Survey of Australians using cannabis for medical purposes. Harm Reduct J 2005; 2(1): 18.
[http://dx.doi.org/10.1186/1477-7517-2-18] [PMID: 16202145]
[31]
Selvarajah D, Gandhi R, Emery CJ, Tesfaye S. Randomized placebo-controlled doubleblind clinical trial of cannabis based medicinal product (Sativex) in painful diabetic neuropathy. Diabetes Care 2010; 33(1): 128-30.
[http://dx.doi.org/10.2337/dc09-1029] [PMID: 19808912]
[32]
Denson TF, Earleywine M. Decreased depression in marijuana users. Addict Behav 2006; 31(4): 738-42.
[http://dx.doi.org/10.1016/j.addbeh.2005.05.052] [PMID: 15964704]
[33]
Fukuda S, Kohsaka H, Takayasu A, et al. Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis. BMC Musculoskelet Disord 2014; 15(1): 275.
[http://dx.doi.org/10.1186/1471-2474-15-275] [PMID: 25115332]
[34]
Bridgeman MB, Daniel T, Abazia DT. Medicinal cannabis: History, pharmacology, and implications for the acute care setting. P&T 2017; 42(3): 180-8.
[35]
Moisto SA, Galizio M, Connors GJ. Drug Use and Abuse. (3rd ed.), New York: Harcourt Brace College Publishers 1999.
[36]
Meiri E, Jhangiani H, Vredenburgh JJ, et al. Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting. Curr Med Res Opin 2007; 23(3): 533-43.
[http://dx.doi.org/10.1185/030079907X167525] [PMID: 17355735]
[37]
Alsasua del Valle A. Implication of cannabinoids in neurological diseases. Cell Mol Neurobiol 2006; 26(4-6): 577-89.
[http://dx.doi.org/10.1007/s10571-006-9070-8] [PMID: 16699878]
[38]
Ayenigbara GO. Cannabis sativa: A plant with multiple utilities, misunderstood, and a victim of controversial hypocrisy. J Emerg Trends Educ Res Policy Stud 2014; 5: 54-9.
[39]
Tashkin DP. Does marijuana pose risks for chronic airflow obstruction? Ann Am Thorac Soc 2015; 12(2): 235-6.
[http://dx.doi.org/10.1513/AnnalsATS.201412-581ED] [PMID: 25706487]
[40]
Fischer B, Imtiaz S, Rudzinski K, Rehm J. Crude estimates of cannabis-attributable mortality and morbidity in Canada–implications for public health focused intervention priorities. J Public Health 2016; 38(1): 183-8.
[http://dx.doi.org/10.1093/pubmed/fdv005] [PMID: 25630540]
[41]
Lai HMX, Sitharthan T. Exploration of the comorbidity of cannabis use disorders and mental health disorders among inpatients presenting to all hospitals in New South Wales, Australia. Am J Drug Alcohol Abuse 2012; 38(6): 567-74.
[http://dx.doi.org/10.3109/00952990.2012.694523] [PMID: 22746224]
[42]
Sanches RF, Marques JMA. Cannabis e humor. Rev Bras Psiquiatr 2010; 32(2): 173-80.
[http://dx.doi.org/10.1590/S1516-44462010000200014] [PMID: 20658056]
[43]
Borges G, Bagge CL, Orozco R. A literature review and meta-analyses of cannabis use and suicidality. J Affect Disord 2016; 195: 63-74.
[http://dx.doi.org/10.1016/j.jad.2016.02.007] [PMID: 26872332]
[44]
du Plessis SS, Agarwal A, Syriac A. Marijuana, phytocannabinoids, the endocannabinoid system, and male fertility. J Assist Reprod Genet 2015; 32(11): 1575-88.
[http://dx.doi.org/10.1007/s10815-015-0553-8] [PMID: 26277482]
[45]
The classification of cannabis under the misuse of drugs act 1971, advisory council on the misuse of drugs. 2002. Available from: https://assets.publishing.service.gov.uk/media/5a7ac2d840f0b66a2fc029f0/cannabis-class-misuse-drugs-act.pdf
[46]
Hazekamp A, Simons R, Peltenburg-Looman A, Sengers M, van Zweden R, Verpoorte R. Preparative isolation of cannabinoids from Cannabis sativa by centrifugal partition chromatography. J Liq Chromatogr Relat Technol 2004; 27(15): 2421-39.
[http://dx.doi.org/10.1081/JLC-200028170]
[47]
Leghissa A, Hildenbrand ZL, Schug KA. A review of methods for the chemical characterization of cannabis natural products. J Sep Sci 2018; 41(1): 398-415.
[http://dx.doi.org/10.1002/jssc.201701003] [PMID: 28986974]
[48]
Citti C, Braghiroli D, Vandelli MA, Cannazza G. Pharmaceutical and biomedical analysis of cannabinoids: A critical review. J Pharm Biomed Anal 2018; 147: 565-79.
[http://dx.doi.org/10.1016/j.jpba.2017.06.003] [PMID: 28641906]
[49]
De Backer B, Debrus B, Lebrun P, et al. Innovative development and validation of an HPLC/DAD method for the qualitative and quantitative determination of major cannabinoids in cannabis plant material. J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877(32): 4115-24.
[http://dx.doi.org/10.1016/j.jchromb.2009.11.004] [PMID: 19932642]
[50]
Aizpurua-Olaizola O, Soydaner U, Öztürk E, et al. Evolution of the cannabinoid and Terpene content during the growth of Cannabis sativa plants from different Chemotypes. J Nat Prod 2016; 79(2): 324-31.
[http://dx.doi.org/10.1021/acs.jnatprod.5b00949] [PMID: 26836472]
[51]
Dallüge J, Beens J, Brinkman UAT. Comprehensive two-dimensional gas chromatography: A powerful and versatile analytical tool. J Chromatogr A 2003; 1000(1-2): 69-108.
[http://dx.doi.org/10.1016/S0021-9673(03)00242-5] [PMID: 12877167]
[52]
Gröger T, Schäffer M, Pütz M, et al. Application of two-dimensional gas chromatography combined with pixel-based chemometric processing for the chemical profiling of illicit drug samples. J Chromatogr A 2008; 1200(1): 8-16.
[http://dx.doi.org/10.1016/j.chroma.2008.05.028] [PMID: 18539290]
[53]
Omar J, Olivares M, Amigo JM, Etxebarria N. Resolution of co-eluting compounds of Cannabis sativa in comprehensive two-dimensional gas chromatography/mass spectrometry detection with multivariate curve resolution-alternating least squares. Talanta 2014; 121: 273-80.
[http://dx.doi.org/10.1016/j.talanta.2013.12.044] [PMID: 24607138]
[54]
Beasley E, Francese S, Bassindale T. Detection and mapping of cannabinoids in single hair samples through rapid derivatization and matrix-assisted laser desorption ionization mass spectrometry. Anal Chem 2016; 88(20): 10328-34.
[http://dx.doi.org/10.1021/acs.analchem.6b03551] [PMID: 27648476]
[55]
Hazekamp A, Peltenburg A, Verpoorte R, Giroud C. Chromatographic and spectroscopic data of cannabinoids from Cannabis sativa. J Liq Chromatogr Relat Technol 2005; 28(15): 2361-82.
[http://dx.doi.org/10.1080/10826070500187558]
[56]
Mutje P. Full exploitation of Cannabis sativa as reinforcement/filler of thermoplastic composite materials. Compos A Appl Sci Manuf 2007; 38(2): 369-77.
[57]
Pourseyed Lazarjani M, Torres S, Hooker T, Fowlie C, Young O, Seyfoddin A. Methods for quantification of cannabinoids: A narrative review. Journal of Cannabis Research 2020; 2(1): 35.
[http://dx.doi.org/10.1186/s42238-020-00040-2] [PMID: 33526084]
[58]
Zuardi AW. History of cannabis as a medicine: A review. Rev Bras Psiquiatr 2006; 28(2): 153-7.
[http://dx.doi.org/10.1590/S1516-44462006000200015] [PMID: 16810401]
[59]
Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993; 365(6441): 61-5.
[http://dx.doi.org/10.1038/365061a0] [PMID: 7689702]
[60]
Devane WA, Hanuš L, Breuer A, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992; 258(5090): 1946-9.
[http://dx.doi.org/10.1126/science.1470919] [PMID: 1470919]
[61]
Stella N, Schweitzer P, Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 1997; 388(6644): 773-8.
[http://dx.doi.org/10.1038/42015] [PMID: 9285589]
[62]
Sugiura T, Kishimoto S, Oka S, Gokoh M. Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. Prog Lipid Res 2006; 45(5): 405-46.
[http://dx.doi.org/10.1016/j.plipres.2006.03.003] [PMID: 16678907]
[63]
Piomelli D. The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 2003; 4(11): 873-84.
[http://dx.doi.org/10.1038/nrn1247] [PMID: 14595399]
[64]
De Petrocellis L, Di Marzo V. An introduction to the endocannabinoid system: From the early to the latest concepts. Best Pract Res Clin Endocrinol Metab 2009; 23(1): 1-15.
[http://dx.doi.org/10.1016/j.beem.2008.10.013] [PMID: 19285257]
[65]
Abouchedid R, Ho JH, Hudson S, et al. Acute toxicity associated with use of 5F-derivations of synthetic cannabinoid receptor agonists with analytical confirmation. J Med Toxicol 2016; 12(4): 396-401.
[http://dx.doi.org/10.1007/s13181-016-0571-7] [PMID: 27456262]
[66]
Huestis MA, Henningfield JE, Cone EJ. Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana. J Anal Toxicol 1992; 16(5): 276-82.
[http://dx.doi.org/10.1093/jat/16.5.276] [PMID: 1338215]
[67]
Lemberger L, Axelrod J, Kopin IJ. Metabolism and disposition of delta-9-tetrahydrocannabinol in man. Pharmacol Rev 1971; 23(4): 371-80.
[PMID: 4943951]
[68]
Goullé JP, Saussereau E, Lacroix C. (Delta-9-tetrahydrocannabinol pharmacokinetics). Ann Pharm Fr 2008; 66(4): 232-44.
[http://dx.doi.org/10.1016/j.pharma.2008.07.006] [PMID: 18847571]
[69]
Vandevenne M, Vandenbussche H, Verstraete A. Detection time of drugs of abuse in urine. Acta Clin Belg 2000; 55(6): 323-33.
[http://dx.doi.org/10.1080/17843286.2000.11754319] [PMID: 11484423]
[70]
Huestis MA. Pharmacokinetics and metabolism of the plant cannabinoids, delta9-tetrahydrocannabinol, cannabidiol and cannabinol. Handb Exp Pharmacol 2005; 168(168): 657-90.
[http://dx.doi.org/10.1007/3-540-26573-2_23] [PMID: 16596792]
[71]
Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet 2003; 42(4): 327-60.
[http://dx.doi.org/10.2165/00003088-200342040-00003] [PMID: 12648025]
[72]
Lindgren JE, Ohlsson A, Agurell S. Clinical effects and plasma levels of delta 9-tetrahydrocannabinol (delta 9-THC) in heavy and light users of cannabis. Psychopharmacology 1981; 74(3): 208-12.
[73]
Wall M, Perez-Reyes M. The metabolism of delta 9-tetrahydrocannabinol and related cannabinoids in man. J Clin Pharmacol 1981; 21(S1): 178S-89S.
[http://dx.doi.org/10.1002/j.1552-4604.1981.tb02594.x] [PMID: 6271823]
[74]
Smith-Kielland A, Skuterud B, Mørland J. Urinary excretion of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and cannabinoids in frequent and infrequent drug users. J Anal Toxicol 1999; 23(5): 323-32.
[http://dx.doi.org/10.1093/jat/23.5.323] [PMID: 10488918]
[75]
Harvey DJ. Metabolism and pharmacokinetics of the cannabinoids. In: Watson RR, Ed. Biochemistry and physiology of substance abuse. Boca Raton, FL: CRC Press 1991; pp. 279-365.
[76]
Hawksworth G, McArdle K. Metabolism and pharmacokinetics of cannabinoids. In: Guy GW, Whittle BA, Robson PJ, Eds. The medicinal uses of cannabis and cannabinoids. London: Pharmaceutical Press 2004; pp. 205-28.
[77]
Huestis MA. Human cannabinoid pharmacokinetics. Chem Biodivers 2007; 4(8): 1770-804.
[http://dx.doi.org/10.1002/cbdv.200790152] [PMID: 17712819]
[78]
Huestis MA, Smith ML. Cannabinoid pharmacokinetics and disposition in alternative matrices. In: Pertwee RG, Ed. Handbook of cannabis. Oxford: Oxford University Press 2014; pp. 296-316.
[http://dx.doi.org/10.1093/acprof:oso/9780199662685.003.0016]
[79]
Devinsky O, Cilio MR, Cross H, et al. Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia 2014; 55(6): 791-802.
[http://dx.doi.org/10.1111/epi.12631] [PMID: 24854329]
[80]
Almogi-Hazan O, Or R. Cannabis, the endocannabinoid system and immunity—the journey from the bedside to the bench and back. Int J Mol Sci 2020; 21(12): 4448.
[http://dx.doi.org/10.3390/ijms21124448] [PMID: 32585801]
[81]
Salzet M, Breton C, Bisogno T, Di Marzo V. Comparative biology of the endocannabinoid system. Eur J Biochem 2000; 267(16): 4917-27.
[http://dx.doi.org/10.1046/j.1432-1327.2000.01550.x] [PMID: 10931174]
[82]
Ingvardsen CR, Brinch-Pedersen H. Challenges and potentials of new breeding techniques in Cannabis sativa. Front Plant Sci 2023; 14: 1154332.
[http://dx.doi.org/10.3389/fpls.2023.1154332] [PMID: 37360738]

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy